procainamide has been researched along with Auricular Flutter in 101 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
" Procainamide is commonly used for conversion of recent-onset atrial fibrillation to normal sinus rhythm." | 9.08 | Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. ( Carberry, PA; Dunn, GH; Kowey, PR; Lewis, WR; Perry, KT; Stambler, B; Vanderlugt, JT; Volgman, AS, 1998) |
"The selective class III antiarrhythmic agent ibutilide prolongs action potential duration and terminates atrial flutter (AFL) and fibrillation (AF), but the mechanism of its antiarrhythmic efficacy in humans has not been fully characterized." | 9.08 | Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1997) |
"This study compares the influence of intravenous ibutilide, a class III antiarrhythmic agent, with procainamide, a class IA antiarrhythmic agent, and with placebo on its ability to terminate atrial flutter using rapid atrial pacing." | 9.08 | Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1996) |
"In a prospective, double-blind, randomized, placebocontrolled study we investigated the facilitating influence of intravenous procainamide on conversion of atrial flutter by rapid atrial pacing." | 9.08 | Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. ( Heisel, A; Jung, J; Schieffer, H; Stopp, M, 1997) |
"This health records review included a consecutive cohort of ED patients with acute-onset atrial fibrillation or atrial flutter who received IV procainamide at one university hospital ED during a five-year period." | 7.74 | Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. ( Clement, CM; Perry, JJ; Stiell, IG; Symington, C; Vaillancourt, C; Wells, GA, 2007) |
"The composition of the excitable gap (EG) in common atrial flutter (AF1) was determined before and during infusion of procainamide (PA) in 9 patients (6 men and 3 women; age 70 +/- 7 years)." | 7.70 | Effects of procainamide on the excitable gap composition in common human atrial flutter. ( Costi, P; Jalil, E; Kús, T; Le Franc, P; Lebeau, R; Molin, F, 1998) |
"The effects of increasing concentrations of procainamide on the composition of the excitable gap were determined in a canine model of atrial flutter." | 7.69 | Effects of procainamide on the excitable gap composition in a canine model of atrial flutter. ( Jalil, E; Kus, T; Laflamme, M, 1997) |
"The effects of procainamide and propafenone on the composition of the excitable gap (EG) were studied in a canine model of atrial flutter (AFI) around the tricuspid valve." | 7.69 | Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia. ( Derakhchan, K; Kus, T; Lambert, C; Pagé, P, 1994) |
" Two patients with chronic atrial fibrillation (who received amiodarone) were later excluded from the analysis." | 7.68 | Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. ( Chapman, MJ; Cunningham, DN; Moran, JL; O'Fathartaigh, MS; Peisach, AR, 1993) |
"The mechanism of atrial flutter and fibrillation induced by rapid pacing in 22 dogs with 3-day-old sterile pericarditis was investigated by computerized epicardial mapping of atrial activation before and after administration of agents known to modify atrial electrophysiologic properties: procainamide, isoproterenol, and electrical stimulation of the vagosympathetic trunks." | 7.68 | Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis. ( Cardinal, R; Hassanalizadeh, H; Pagé, PL, 1991) |
" We evaluated frequency-dependence of excitability and refractoriness before and after flecainide or procainamide administration in relation to termination of reentrant atrial flutter." | 7.68 | Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects. ( Bel, KJ; Crijns, HJ; de Langen, CD; Ebels, T; Grandjean, JG; Lie, KI; Wesseling, H, 1993) |
"To evaluate the mechanisms of action of procainamide on the components of the reentrant pathway, drug-induced changes in activation patterns, effective refractory periods (ERPs), and stimulation thresholds were analyzed in nine dogs with sterile pericarditis and sustained atrial flutter." | 7.68 | Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway. ( el-Sherif, N; Gough, WB; Schoels, W; Yang, H, 1991) |
"We studied the effects of procainamide and N-acetylprocainamide (NAPA) in a conscious dog preparation of atrial flutter resulting from circus movement around the tricuspid orifice." | 7.67 | Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro. ( Hoffman, BF; Wu, KM, 1987) |
" The effects of NAPA (25 mg/kg intravenously) on sustained, stable, reentrant atrial flutter induced in 12 conscious dogs using a sterile pericarditis model were studied and compared with the effects of quinidine (5 mg/kg intravenously) given on a different day in 10 of the same 12 dogs." | 7.67 | Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine. ( Okumura, K; Waldo, AL, 1987) |
"Seven cases of procainamide-induced polymorphous ventricular tachycardia are presented." | 7.66 | Procainamide-induced polymorphous ventricular tachycardia. ( Agmon, J; Duffy, CE; Erdberg, A; Lam, W; Rosen, KM; Sclarovsky, S; Strasberg, B; Swiryn, S, 1981) |
"The selective class III antiarrhythmic agent ibutilide prolongs action potential duration and terminates atrial flutter (AFL) and fibrillation (AF), but the mechanism of its antiarrhythmic efficacy in humans has not been fully characterized." | 5.08 | Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1997) |
"This study compares the influence of intravenous ibutilide, a class III antiarrhythmic agent, with procainamide, a class IA antiarrhythmic agent, and with placebo on its ability to terminate atrial flutter using rapid atrial pacing." | 5.08 | Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1996) |
" Procainamide is commonly used for conversion of recent-onset atrial fibrillation to normal sinus rhythm." | 5.08 | Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. ( Carberry, PA; Dunn, GH; Kowey, PR; Lewis, WR; Perry, KT; Stambler, B; Vanderlugt, JT; Volgman, AS, 1998) |
"In a prospective, double-blind, randomized, placebocontrolled study we investigated the facilitating influence of intravenous procainamide on conversion of atrial flutter by rapid atrial pacing." | 5.08 | Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing. ( Heisel, A; Jung, J; Schieffer, H; Stopp, M, 1997) |
" Unlike the case of atrial fibrillation, we found that IV procainamide alone was infrequently effective." | 4.02 | A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutter. ( Birnie, D; Borgundvaag, B; Brinkhurst, J; Brison, RJ; Brown, E; Clement, CM; Hohl, CM; Macle, L; McRae, AD; Mercier, E; Morris, J; Nemnom, MJ; Perry, JJ; Rowe, BH; Sivilotti, MLA; Stiell, IG; Taljaard, M; Thiruganasambandamoorthy, V; Vadeboncoeur, A; Wells, GA, 2021) |
"This health records review included a consecutive cohort of ED patients with acute-onset atrial fibrillation or atrial flutter who received IV procainamide at one university hospital ED during a five-year period." | 3.74 | Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter. ( Clement, CM; Perry, JJ; Stiell, IG; Symington, C; Vaillancourt, C; Wells, GA, 2007) |
"The composition of the excitable gap (EG) in common atrial flutter (AF1) was determined before and during infusion of procainamide (PA) in 9 patients (6 men and 3 women; age 70 +/- 7 years)." | 3.70 | Effects of procainamide on the excitable gap composition in common human atrial flutter. ( Costi, P; Jalil, E; Kús, T; Le Franc, P; Lebeau, R; Molin, F, 1998) |
" Six of the 112 episodes required an infusion of procainamide after initial attempts at pacing led to atrial fibrillation." | 3.69 | Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. ( Rhodes, LA; Saul, JP; Walsh, EP, 1995) |
"The effects of increasing concentrations of procainamide on the composition of the excitable gap were determined in a canine model of atrial flutter." | 3.69 | Effects of procainamide on the excitable gap composition in a canine model of atrial flutter. ( Jalil, E; Kus, T; Laflamme, M, 1997) |
"The effects of procainamide and propafenone on the composition of the excitable gap (EG) were studied in a canine model of atrial flutter (AFI) around the tricuspid valve." | 3.69 | Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia. ( Derakhchan, K; Kus, T; Lambert, C; Pagé, P, 1994) |
" Two patients with chronic atrial fibrillation (who received amiodarone) were later excluded from the analysis." | 3.68 | Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone. ( Chapman, MJ; Cunningham, DN; Moran, JL; O'Fathartaigh, MS; Peisach, AR, 1993) |
"The effects of procainamide were studied in a model of atrial flutter around the tricuspid valve in seven open chest, chloralose-anesthetized dogs (31 +/- 3 kg)." | 3.68 | Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia. ( Bouchard, C; Derakhchan, K; Kus, T; Pagé, P, 1991) |
"To evaluate the mechanisms of action of procainamide on the components of the reentrant pathway, drug-induced changes in activation patterns, effective refractory periods (ERPs), and stimulation thresholds were analyzed in nine dogs with sterile pericarditis and sustained atrial flutter." | 3.68 | Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway. ( el-Sherif, N; Gough, WB; Schoels, W; Yang, H, 1991) |
"The mechanism of atrial flutter and fibrillation induced by rapid pacing in 22 dogs with 3-day-old sterile pericarditis was investigated by computerized epicardial mapping of atrial activation before and after administration of agents known to modify atrial electrophysiologic properties: procainamide, isoproterenol, and electrical stimulation of the vagosympathetic trunks." | 3.68 | Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis. ( Cardinal, R; Hassanalizadeh, H; Pagé, PL, 1991) |
" We evaluated frequency-dependence of excitability and refractoriness before and after flecainide or procainamide administration in relation to termination of reentrant atrial flutter." | 3.68 | Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects. ( Bel, KJ; Crijns, HJ; de Langen, CD; Ebels, T; Grandjean, JG; Lie, KI; Wesseling, H, 1993) |
" The effects of NAPA (25 mg/kg intravenously) on sustained, stable, reentrant atrial flutter induced in 12 conscious dogs using a sterile pericarditis model were studied and compared with the effects of quinidine (5 mg/kg intravenously) given on a different day in 10 of the same 12 dogs." | 3.67 | Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine. ( Okumura, K; Waldo, AL, 1987) |
"We studied the effects of procainamide and N-acetylprocainamide (NAPA) in a conscious dog preparation of atrial flutter resulting from circus movement around the tricuspid orifice." | 3.67 | Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro. ( Hoffman, BF; Wu, KM, 1987) |
" The prevention of ventricular arrhythmias with prophylactic lidocaine is advocated for patients with suspected acute myocardial infarction." | 3.66 | Therapeutic considerations in the treatment of common cardiac arrhythmias. ( Hart, NJ, 1981) |
", verapamil, disopyramide, and procainamide, on paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (Af) and atrial flutter (AF) were evaluated electrophysiologically." | 3.66 | Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias. ( Hiejima, K; Satake, S; Suzuki, F; Takahashi, M, 1983) |
"Seven cases of procainamide-induced polymorphous ventricular tachycardia are presented." | 3.66 | Procainamide-induced polymorphous ventricular tachycardia. ( Agmon, J; Duffy, CE; Erdberg, A; Lam, W; Rosen, KM; Sclarovsky, S; Strasberg, B; Swiryn, S, 1981) |
"Atrial flutter has a fully excitable gap, and procainamide does not convert the gap from full to partial excitability." | 1.29 | Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit. ( Ellenbogen, KA; Stambler, BS; Wood, MA, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 71 (70.30) | 18.7374 |
1990's | 23 (22.77) | 18.2507 |
2000's | 3 (2.97) | 29.6817 |
2010's | 3 (2.97) | 24.3611 |
2020's | 1 (0.99) | 2.80 |
Authors | Studies |
---|---|
Stiell, IG | 5 |
Sivilotti, MLA | 1 |
Taljaard, M | 1 |
Birnie, D | 4 |
Vadeboncoeur, A | 1 |
Hohl, CM | 1 |
McRae, AD | 1 |
Morris, J | 1 |
Mercier, E | 1 |
Macle, L | 1 |
Brison, RJ | 3 |
Thiruganasambandamoorthy, V | 1 |
Rowe, BH | 3 |
Borgundvaag, B | 3 |
Clement, CM | 5 |
Brinkhurst, J | 1 |
Brown, E | 1 |
Nemnom, MJ | 1 |
Wells, GA | 4 |
Perry, JJ | 5 |
Vaillancourt, C | 2 |
Symington, C | 2 |
Dickinson, G | 1 |
Green, MS | 1 |
Langhan, T | 2 |
Lang, E | 2 |
Magee, K | 2 |
Stenstrom, R | 2 |
Blecher, GE | 1 |
KLOPPE, W | 1 |
BERNSTEIN, LM | 1 |
PASCALE, LR | 1 |
SCHOOLMAN, HM | 1 |
FOLEY, EF | 1 |
CALVERT, R | 1 |
SMITH, E | 1 |
CANIGGIA, A | 1 |
BERTELLI, G | 1 |
KUBICEK, F | 1 |
FINARDI, G | 1 |
HURWITZ, M | 1 |
ELIOT, RS | 2 |
REYNOLDS, EW | 1 |
BAIRD, WM | 1 |
CLIFFORD, ME | 1 |
BERNSTEIN, H | 1 |
GOLD, H | 1 |
LANG, TW | 1 |
PAPPELBAUM, S | 1 |
BAZIKA, V | 1 |
CORDAY, E | 1 |
FOERSTER, K | 1 |
KROETZ, C | 1 |
MILLER, G | 1 |
WEINBERG, SL | 1 |
PICK, A | 1 |
Lebedewa, RN | 1 |
Tschirdewahn, B | 1 |
Knorpp, K | 1 |
Heinrich, F | 2 |
Schütterle, G | 1 |
Ferlic, RM | 1 |
Sellers, RD | 1 |
Lillehei, CW | 1 |
Willoughby, ML | 1 |
Dunlap, DB | 1 |
Hart, NJ | 1 |
Olesin, AI | 1 |
Andriushchenko, OM | 1 |
Hiejima, K | 1 |
Suzuki, F | 1 |
Takahashi, M | 1 |
Satake, S | 1 |
Uzilevskaia, RA | 1 |
Grishkin, IuN | 1 |
Friedman, PL | 1 |
Brugada, P | 1 |
Kuck, KH | 1 |
Roy, D | 1 |
Farre, J | 1 |
Bär, FW | 1 |
Wellens, HJ | 1 |
Strasberg, B | 1 |
Sclarovsky, S | 1 |
Erdberg, A | 1 |
Duffy, CE | 1 |
Lam, W | 1 |
Swiryn, S | 1 |
Agmon, J | 1 |
Rosen, KM | 1 |
Rhodes, LA | 1 |
Walsh, EP | 1 |
Saul, JP | 1 |
Crijns, HJ | 1 |
de Langen, CD | 1 |
Grandjean, JG | 1 |
Bel, KJ | 1 |
Ebels, T | 1 |
Lie, KI | 1 |
Wesseling, H | 1 |
Botteron, GW | 1 |
Smith, JM | 1 |
Derakhchan, K | 2 |
Pagé, P | 2 |
Lambert, C | 1 |
Kus, T | 4 |
Müller, GI | 1 |
Deal, BJ | 1 |
Strasburger, JF | 1 |
Benson, DW | 1 |
Chapman, MJ | 1 |
Moran, JL | 1 |
O'Fathartaigh, MS | 1 |
Peisach, AR | 1 |
Cunningham, DN | 1 |
Stambler, BS | 3 |
Wood, MA | 3 |
Ellenbogen, KA | 3 |
Ohga, N | 1 |
Inoue, T | 3 |
Doi, T | 1 |
Yoshida, A | 1 |
Yokoyama, M | 1 |
Matiouchine, GV | 1 |
Shulman, VA | 1 |
Balog, AI | 1 |
Bezruk, AP | 1 |
Golovenkin, SE | 1 |
Jalil, E | 2 |
Laflamme, M | 1 |
Heisel, A | 1 |
Jung, J | 1 |
Stopp, M | 1 |
Schieffer, H | 1 |
Tai, CT | 1 |
Chen, SA | 1 |
Chiang, CE | 1 |
Lee, SH | 1 |
Ueng, KC | 1 |
Wen, ZC | 1 |
Huang, JL | 1 |
Chen, YJ | 1 |
Yu, WC | 1 |
Feng, AN | 1 |
Chiou, CW | 1 |
Chang, MS | 1 |
Le Franc, P | 1 |
Lebeau, R | 1 |
Molin, F | 1 |
Costi, P | 1 |
Volgman, AS | 1 |
Carberry, PA | 1 |
Stambler, B | 1 |
Lewis, WR | 1 |
Dunn, GH | 1 |
Perry, KT | 1 |
Vanderlugt, JT | 1 |
Kowey, PR | 1 |
Martinez-Lopez, JI | 1 |
Naccarelli, GV | 1 |
Dell'Orfano, JT | 1 |
Wolbrette, DL | 1 |
Patel, HM | 1 |
Luck, JC | 1 |
Rostás, L | 1 |
Antal, K | 1 |
Putorek, Z | 1 |
Morita, N | 1 |
Kobayashi, Y | 1 |
Iwasaki, YK | 1 |
Hayashi, M | 1 |
Atarashi, H | 1 |
Katoh, T | 1 |
Takano, T | 1 |
Donaldson, RM | 1 |
Anshelevich, IuV | 1 |
Sorokina, TA | 1 |
Bekere, FA | 1 |
Slaĭdyn', AK | 1 |
Beer, ET | 1 |
Orlando, J | 1 |
Aronow, WS | 2 |
Tonkin, AM | 1 |
Gallagher, JJ | 1 |
Wallace, AG | 1 |
Bouchard, C | 1 |
Schoels, W | 1 |
Yang, H | 1 |
Gough, WB | 1 |
el-Sherif, N | 1 |
Pagé, PL | 1 |
Hassanalizadeh, H | 1 |
Cardinal, R | 1 |
Olshansky, B | 2 |
Okumura, K | 3 |
Hess, PG | 2 |
Waldo, AL | 3 |
Grosu, AA | 1 |
Shevchenko, NM | 1 |
Wu, KM | 1 |
Hoffman, BF | 1 |
Feld, GK | 1 |
Venkatesh, N | 1 |
Singh, BN | 1 |
Fujimoto, T | 1 |
Ogawa, H | 1 |
Miwa, S | 1 |
Ohnishi, Y | 1 |
Yoneda, N | 1 |
Kaneda, S | 2 |
Itoh, S | 1 |
Fukuzaki, H | 2 |
Henthorn, RW | 1 |
Inoue, H | 1 |
Zipes, DP | 1 |
Nolan, PE | 1 |
Fenster, PE | 1 |
Dunnigan, A | 1 |
Benson, W | 1 |
Benditt, DG | 1 |
Ivanova, TN | 1 |
Pavlova, LT | 1 |
Schollmeyer, P | 2 |
Tuveri, A | 1 |
Gentili, MC | 1 |
Rodriguez Teran, Y | 1 |
Quattrini, L | 1 |
De Luca, FM | 1 |
Hardewig, A | 1 |
Diedrich, R | 1 |
Hurwitz, RA | 1 |
Kaufmann, G | 1 |
Chatillon, J | 1 |
Fakhro, AM | 1 |
Ritchie, RF | 1 |
Lown, B | 1 |
Alekseev, GK | 2 |
Born, H | 1 |
Schultis, K | 1 |
Robinson, SJ | 1 |
Donat, K | 1 |
Covino, BG | 1 |
D'Amato, HE | 1 |
Helfant, RH | 1 |
Seuffert, GW | 1 |
Patton, RD | 1 |
Stein, E | 1 |
Damato, AN | 2 |
Raynaud, R | 1 |
Morand, P | 1 |
Fauchier, JP | 1 |
Hénin, JM | 1 |
Delineau, MA | 1 |
Joulain, R | 1 |
Garnier, D | 1 |
Gargouïl, YM | 1 |
Resnekov, L | 1 |
Bender, F | 1 |
Messini, M | 1 |
Kato, K | 1 |
Iinuma, H | 1 |
Babskii, EB | 2 |
Makarychev, VA | 2 |
Orlov, VN | 2 |
Drayer, DE | 1 |
Reidenberg, MM | 1 |
Sevy, RW | 1 |
Martynov, IV | 1 |
Tikhonov, AA | 1 |
Zhibkov, IuE | 1 |
Bakulin, VD | 1 |
Lau, SH | 1 |
Marriott, HJ | 1 |
Beller, BM | 1 |
Trevino, A | 1 |
Talley, R | 1 |
Cutler, P | 1 |
Baum, T | 1 |
Eckfeld, DK | 1 |
Shropshire, AT | 1 |
Rowles, G | 1 |
Varner, LL | 1 |
Mitsui, T | 1 |
Esser, H | 1 |
Fricke, G | 1 |
Forster, G | 1 |
Xenakis, E | 1 |
Costeas, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Controlled Comparison of Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Recent-Onset Atrial Fibrillation and Flutter (RAFF)[NCT01891058] | 396 participants (Actual) | Interventional | 2013-07-18 | Completed | |||
DiME Study: Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Response: A Prospective Randomized and Double-Blinded Non-Inferiority Trial of Safety and Efficacy[NCT01914926] | Phase 4 | 54 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Percent of patient who reached a HR<100bpm within 30 minutes from baseline. (NCT01914926)
Timeframe: 30 minutes
Intervention | percentage of participants (Number) |
---|---|
Metoprolol Study Group | 46.4 |
Diltiazem Study Group | 95.8 |
13 reviews available for procainamide and Auricular Flutter
Article | Year |
---|---|
The treatment of atrial fibrillation and flutter: a review.
Topics: Adrenergic beta-Antagonists; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Ar | 1984 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit An | 2000 |
Management of supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Huma | 1989 |
[Cardiac arrhythmias. I. Pathogenesis and clinical significance].
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillat | 1971 |
Cardiac arrhythmias in infants and children.
Topics: Adolescent; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardi | 1973 |
[Anti-arrhythmia agents].
Topics: Action Potentials; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atri | 1974 |
Treatment of cardiac arrhythmias.
Topics: Adams-Stokes Syndrome; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1964 |
Current status of antiarrhythmic drug therapy.
Topics: Anesthetics, Local; Anti-Arrhythmia Agents; Anticonvulsants; Antimalarials; Arrhythmias, Cardiac; At | 1968 |
Cardiac arrhythmias. 6. Present status of electroversion in the management of cardiac dysrhythmias.
Topics: Anticoagulants; Arrhythmias, Cardiac; Atrial Flutter; Cardiomegaly; Digitalis Glycosides; Electric C | 1973 |
[Therapy of total arrhythmia due to atrial fibrillation and flutter].
Topics: Anticoagulants; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Ele | 1971 |
[Treatment of fibrillation and flutter].
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Electric Countershock; Humans; Male | 1974 |
Clinical value of the electrogram of the conduction system.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Atropine; Bundle-Branch Block; Cardiac Catheterization; C | 1970 |
Management of cardiac dysrhythmias complicating acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; Bretylium Compound | 1968 |
7 trials available for procainamide and Auricular Flutter
Article | Year |
---|---|
Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Double-Blind Method; Electric Countershock; Electrocar | 1996 |
Effects of class IA antiarrhythmic drugs on the reentrant circuit in common human atrial flutter.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Disopyramide; Elect | 1995 |
Facilitating influence of procainamide on conversion of atrial flutter by rapid atrial pacing.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Double-Blind Method | 1997 |
Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electro | 1997 |
Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Electric Cou | 1998 |
Transesophageal pacemaker therapy in atrial flutter after procainamide pretreatment.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Electric C | 1999 |
Clinical value of the electrogram of the conduction system.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Atropine; Bundle-Branch Block; Cardiac Catheterization; C | 1970 |
82 other studies available for procainamide and Auricular Flutter
Article | Year |
---|---|
A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Emergency Servic | 2021 |
Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinica | 2010 |
Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial | 2011 |
Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; | 2012 |
[Auricular flutter and fibrillation and their response to novocamide].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction Syst | 1954 |
Intravenous procaine amide as an aid to differentiate auricular flutter with bundle branch block from paroxysmal ventricular tachycardia.
Topics: Atrial Flutter; Bundle-Branch Block; Cardiac Conduction System Disease; Diagnosis, Differential; Ele | 1954 |
Procaine amide therapy in auricular flutter with 1:1 A-V conduction.
Topics: Atrial Flutter; Coronary Disease; Heart Rate; Humans; Procainamide | 1954 |
[Esophageal electrocardiogram in paroxysmal tachycardia & auricular flutter before & after quinidine & procaine amide therapy].
Topics: Atrial Flutter; Electrocardiography; Humans; Procainamide; Quinidine; Tachycardia; Tachycardia, Paro | 1957 |
[Successful intracardiac injection of novocainamide in cardiac arrest due to auricular flutter].
Topics: Atrial Flutter; Heart; Heart Arrest; Humans; Procainamide; Punctures | 1958 |
[Ventricular paroxysmal pseudo-tachycardia. Apropos of a case of auricular tachysystole with bundle branch block simulating ventricular paroxysmal tachycardia. Importance of the use of procaine amide for the differential diagnosis].
Topics: Atrial Flutter; Bundle-Branch Block; Cardiac Conduction System Disease; Diagnosis, Differential; Hea | 1960 |
ARRHYTHMIAS IN ACUTE MYOCARDIAL INFARCTION.
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Biomedical Research; B | 1964 |
A CLINICAL TRIAL OF ANTAZOLINE IN THE TREATMENT OF ARRHYTHMIAS.
Topics: Antazoline; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; | 1964 |
SODIUM DIPHENYLHYDANTOIN IN THE TREATMENT OF RECURRENT CARDIAC ARRHYTHMIAS.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Drug Therapy; Geriatrics; Humans; Phenyto | 1965 |
[ANTI-ARRHYTHMIC SUBSTANCES IN THE TREATMENT OF THE HEART].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Drug Ther | 1965 |
The effect of procaine amide (pronestyl) in clinical auricular fibrillation and flutter.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Humans; Procainamide; Procaine | 1952 |
Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electri | 2007 |
[The emergency treatment of acute disorders of heart rhythm following surgical intervention in the thoracic cavity].
Topics: Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Heart Defects, Cong | 1966 |
[Life-threatening disorders of the heart rhythm and beta receptor blocking agents].
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Female; Humans; Isoproterenol; Mal | 1967 |
Cardioversion as an adjunct to cardiac surgery.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Chronic Dis | 1967 |
Therapeutic considerations in the treatment of common cardiac arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes | 1981 |
[The role of the Schlomck-Reindell arrhythmic index and corrected coefficient in the prognosis of atrioventricular block during novocainamide treatment of paroxysms of atrial fibrillation and flutter].
Topics: Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Electrocardiography; Heart Block; Humans | 1983 |
Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Disopyramide; El | 1983 |
[Treatment of paroxysmal forms of auricular fibrillation and atrial flutter in a cardiological hospital].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Glycosides; Drug T | 1983 |
Inter- and intraatrial dissociation during spontaneous atrial flutter: evidence for a focal origin of the arrhythmia.
Topics: Adult; Aged; Atrial Flutter; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Fem | 1982 |
Procainamide-induced polymorphous ventricular tachycardia.
Topics: Administration, Oral; Aged; Atrial Flutter; Electrocardiography; Female; Humans; Injections, Intrave | 1981 |
Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure.
Topics: Adolescent; Adult; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Child; Child, Pr | 1995 |
Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects.
Topics: Animals; Atrial Flutter; Electrocardiography; Flecainide; Heart Conduction System; Male; Procainamid | 1993 |
A technique for measurement of the extent of spatial organization of atrial activation during atrial fibrillation in the intact human heart.
Topics: Adenosine; Atrial Fibrillation; Atrial Flutter; Cardiac Catheterization; Electrocardiography; Electr | 1995 |
Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
Topics: Action Potentials; Anesthesia; Animals; Atrial Flutter; Atrial Function; Chloralose; Diastole; Disea | 1994 |
Electrocardiographic features of atrial tachycardias after operation for congenital heart disease.
Topics: Adolescent; Adult; Atrial Flutter; Child; Child, Preschool; Digoxin; Electrocardiography; Female; He | 1993 |
Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.
Topics: Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Rate; Humans; I | 1993 |
Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
Topics: Action Potentials; Adenosine; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artifici | 1996 |
Combined transesophageal left atrial pacing and antiarrhythmic therapy in the treatment of atrial flutter.
Topics: Ambulatory Care; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Fun | 1996 |
Effects of procainamide on the excitable gap composition in a canine model of atrial flutter.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Diastole; Disease Models, Animal | 1997 |
Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Catheterization; Electrophy | 1997 |
Effects of procainamide on the excitable gap composition in common human atrial flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Catheterization; Electrocardiography; Female; | 1998 |
ECG of the month. Orderly misconduct. Atrial flutter.
Topics: Anti-Arrhythmia Agents; Atrial Flutter; Diagnosis, Differential; Electric Countershock; Electrocardi | 1999 |
Pronounced effect of procainamide on clockwise right atrial isthmus conduction compared with counterclockwise conduction: possible mechanism of the greater incidence of common atrial flutter during antiarrhythmic therapy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Right; Ch | 2002 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
[Effectiveness of treatment of paroxysms of auricular flutter].
Topics: Adult; Aged; Ajmaline; Anti-Arrhythmia Agents; Atrial Flutter; Electric Countershock; Humans; Middle | 1979 |
Treatment of supraventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Digi | 1979 |
Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.
Topics: Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bundle of His; Child; Drug Therapy | 1976 |
Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia.
Topics: Animals; Atrial Flutter; Atrial Function; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Fem | 1991 |
Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway.
Topics: Animals; Atrial Flutter; Disease Models, Animal; Dogs; Electrocardiography; Heart; Heart Conduction | 1991 |
Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dogs; El | 1991 |
Demonstration of an area of slow conduction in human atrial flutter.
Topics: Atrial Flutter; Atrial Function, Right; Cardiac Pacing, Artificial; Electrocardiography; Heart Condu | 1990 |
[The potentials for curing atrial flutter by the combined use of transesophageal electrical stimulation and anti-arrhythmia preparations].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Flutter; Cardiac Pacing, Artificial; Chronic Disease; Co | 1990 |
Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
Topics: Acecainide; Animals; Atrial Flutter; Consciousness; Differential Threshold; Dogs; Electrophysiology; | 1987 |
Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro.
Topics: Acecainide; Action Potentials; Animals; Atrial Flutter; Dogs; Electrocardiography; Humans; In Vitro | 1987 |
Effects of N-acetylprocainamide and recainam in the pharmacologic conversion and suppression of experimental canine atrial flutter: significance of changes in refractoriness and conduction.
Topics: Acecainide; Anesthesia; Animals; Anti-Arrhythmia Agents; Atrial Flutter; Dogs; Electrocardiography; | 1988 |
The effects of class IA antiarrhythmic drug on the common type of atrial flutter in combination with pacing therapy.
Topics: Adult; Aged; Atrial Flutter; Cardiac Pacing, Artificial; Combined Modality Therapy; Disopyramide; El | 1989 |
Treatment of atrial flutter and rapid atrial tachycardia with transesophageal atrial pacing.
Topics: Aged; Atrial Flutter; Cardiac Pacing, Artificial; Electrocardiography; Esophagus; Female; Heart Cond | 1989 |
Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm.
Topics: Adolescent; Adult; Aged; Atrial Flutter; Cardiac Pacing, Artificial; Combined Modality Therapy; Elec | 1988 |
Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Dogs; Electrocardiography; | 1987 |
The treatment of atrial fibrillation and flutter.
Topics: Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Infusions, Parenteral; Procainam | 1985 |
Atrial flutter in infancy: diagnosis, clinical features, and treatment.
Topics: Atrial Flutter; Cardiac Pacing, Artificial; Combined Modality Therapy; Digoxin; Electric Countershoc | 1985 |
[Correction of arrhythmia in the complex treatment of cardiac insufficiency and heart defects].
Topics: Adolescent; Adult; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Prema | 1970 |
[Cardiac rhythm disorders. 2. Therapy].
Topics: Adrenergic alpha-Antagonists; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial F | 1971 |
[Therapy of atrial and ventricular tachysystole by means of high frequency electrostimulation].
Topics: Adult; Aged; Arteriosclerosis; Atrial Flutter; Cardiac Complexes, Premature; Electric Countershock; | 1969 |
[What is assured in the treatment of heart arrhythmia?].
Topics: Adrenergic beta-Antagonists; Ajmaline; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; C | 1972 |
[The treatment of cardiac arrhythmias: complexity and schematization].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atri | 1973 |
Lupus-like syndrome induced by procainamide.
Topics: Adult; Aged; Antibodies, Antinuclear; Atrial Fibrillation; Atrial Flutter; Autoantibodies; Fluoresce | 1967 |
[Observations on the treatment of certain forms of arrhythmia using contemporary methods].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Card | 1968 |
[Therapeutic possibilities in the treatment of myocardial infarcts combined with arrhythmia].
Topics: Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Digit | 1967 |
[II. Drug therapy of heart rhythm disorders].
Topics: Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature; Heart Block; Humans; Procainamid | 1967 |
[The attack-like heart gallop].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Cardiac Gly | 1968 |
The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.
Topics: Anesthesia, General; Anesthesia, Inhalation; Arrhythmias, Cardiac; Atrial Flutter; Blood Pressure De | 1969 |
[Auricular tachysystoles. Apropos of 25 cases].
Topics: Adult; Aged; Arrhythmia, Sinus; Atrial Fibrillation; Atrial Flutter; Bundle-Branch Block; Cardiac Co | 1969 |
[Measurement of the thresholds of appearance of auricular flutter in relation to the concentration of antifibrillary substances].
Topics: Animals; Atrial Flutter; Dogs; Electrocardiography; Oxytocin; Procainamide; Quinidine | 1967 |
Medical treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrilla | 1971 |
Treatment of cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis; Digoxin; Electric Countershock | 1974 |
[The effect of quinidine and novocainamide on auricular flutter and fibrillation and the effectiveness of defibrillatory discharges under experimental conditions].
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Dogs; Electric Countershock; Procainamide; Quinidine | 1973 |
[Effect of quinidine and novocainamid on atrial flutter and fibrillation and the effectiveness of a defibrillating discharge in an experiment].
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Dogs; Dose-Response Relationship, Drug; Electric Count | 1973 |
N-acetylprocainamide: an active metabolite of procainamide.
Topics: Animals; Arrhythmias, Cardiac; Atrial Flutter; Dose-Response Relationship, Drug; Electrocardiography | 1974 |
[Evaluation of some methods of treating cardiac arrhythmias].
Topics: Adams-Stokes Syndrome; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillatio | 1974 |
Refractory supraventricular arrhythmias in the elderly. Treatment with permanent demand pacing and cardiac drugs.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Bradycardia; Digita | 1971 |
Observations on models used for the evaluation of antiarrhythmic drugs.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutte | 1971 |
DC countershock for cardiac arrhythmias.
Topics: Adult; Atrial Fibrillation; Atrial Flutter; Atropa belladonna; Coronary Disease; Electric Countersho | 1966 |
[Therapy of the most important cardiac arrhythmias].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Bradycardia; Electric Countershock; Gluca | 1970 |
[The therapy of heart rhythm disorders].
Topics: Arrhythmias, Cardiac; Atrial Flutter; Bradycardia; Digitalis; Digitalis Glycosides; Electrocardiogra | 1967 |
[Transitional ventricular complexes in the diagnosis of paroxysmal ventricular tachycardia. Diagnostic contribution of procaine amide].
Topics: Adult; Atrial Flutter; Diagnosis, Differential; Electrocardiography; Female; Humans; Male; Middle Ag | 1966 |
Drugs for cardiac arrhythmias associated with myocardial infarction.
Topics: Atrial Fibrillation; Atrial Flutter; Humans; Myocardial Infarction; Procainamide; Quinidine; Tachyca | 1966 |